Cargando…
A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance
More than one year into a global pandemic, SARS-CoV-2 is now defined by a variety of rapidly evolving variant lineages. Several FDA authorized molecular diagnostic tests have been impacted by viral variation, while no reports of viral variation affecting antigen test performance have occurred to dat...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219478/ https://www.ncbi.nlm.nih.gov/pubmed/34171548 http://dx.doi.org/10.1016/j.jcv.2021.104900 |